Endocrine Abstracts

Bariatric surgery, in particular, Roux-en-Y gastric bypass (RYGB), is the most effective treatment for morbid obesity. The restricted gastric capacity and reduced absorption of nutrients cannot account for all the metabolic benefit we observe post-operation. Therefore, we applied metabolic and microbial profiling approach to investigate the potential mechanisms of RYGB surgery. Metabolic profiling strategy is widely applied in the discovery and development of metabolic biomark...

Background: Circulating levels of the appetite-suppressing and glucoregulatory gut hormones glucagon-like peptide 1 (GLP-1) and peptide tyrosine tyrosine 3–36 (PYY3–36) are markedly increased after Roux-en-Y gastric bypass surgery (RYGB), which may contribute to some of its profound metabolic benefits in morbidly obese individuals.Objectives: To directly compare the metabolic effects of chronic systemic administration of the clinic...

Effects of Bariatric Surgery in Patients with CraniopharyngiomaObjectives: The prime objective of this study is the identification of the limiting factors of metabolic surgeries on weight reduction in patients with craniopharyngioma (CP) and consecutive hypothalamic obesity (HO).Patients: As of now, 37 patients were included, of which5 patients presented with HO and earlier bariatric surgery (mean BMI 50.44 kg/m2), ...